NCT07163637View on ClinicalTrials.gov

Effect of Limosilactobacillus Reuteri DSM 17648 in Healthy Adults Reporting Upper Gastrointestinal Discomfort

NARecruitingINTERVENTIONAL
Enrollment

324

Participants

Timeline

Start Date

September 8, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions
Healthy ParticipantsUpper Gastrointestinal Discomfort
Interventions
DIETARY_SUPPLEMENT

Limosilactobacillus reuteri DSM 17648

One capsule containing L. reuteri DSM 17648 should be taken once per day with liquid during or immediately after the main meal, for 8 weeks.

DIETARY_SUPPLEMENT

Placebo

One capsule of placebo should be taken once per day with liquid during or immediately after the main meal, for 8 weeks.

Trial Locations (1)

89118

RECRUITING

Citruslabs, Las Vegas

Sponsors

Lead Sponsor

Novozymes A/S

Collaborators (1)

Citruslabs
All Listed Sponsors
collaborator

Citruslabs

INDUSTRY

lead

Novozymes A/S

INDUSTRY

NCT07163637 - Effect of Limosilactobacillus Reuteri DSM 17648 in Healthy Adults Reporting Upper Gastrointestinal Discomfort | Biotech Hunter | Biotech Hunter